CPT® Code 88248

1. Indications

The chromosome analysis for breakage syndromes, as outlined in CPT® Code 88248, is indicated for the following conditions:

• Ataxia Telangiectasia - A genetic disorder that affects the nervous system and immune system, characterized by progressive neurological problems and an increased risk of cancer.
• Fanconi Anemia - A rare genetic disorder leading to bone marrow failure, physical abnormalities, and an increased risk of cancer, particularly acute myeloid leukemia.
• Fragile X Syndrome - A genetic condition causing intellectual disability, behavioral challenges, and various physical features, often associated with a mutation in the FMR1 gene.

2. Procedure

The procedure for chromosome analysis for breakage syndromes involves several critical steps to ensure accurate results:

• Cell Culture - Peripheral blood lymphocytes are collected and cultured in a controlled laboratory environment. This process involves stimulating the lymphocytes to divide using a specific antigen, such as phytohemagglutinin, which promotes cell division and allows for the observation of chromosomes during the metaphase stage.
• Chromosome Preparation - A spindle inhibitor is added to the culture to halt the cells in metaphase, ensuring that a sufficient number of mitotic cells are available for analysis. This step is crucial for obtaining clear and usable chromosome samples.
• Staining and Scoring - Bromo-deoxy-uridine (BrdU) is incorporated into the culture medium for two complete cell cycles, allowing for differential staining of chromatids. The analysis involves scoring 50 to 100 cells, with a detailed count of 20 cells to identify any chromosomal abnormalities. The stained chromosomes are then examined under a microscope to detect any structural changes.
• Karyotyping - Two karyotypes are performed to evaluate the size, shape, and number of chromosomes. This involves using banding techniques, such as Giemsa banding, to visualize the chromosomes and identify any extra, missing, or abnormal chromosome segments. The presence of two karyotypes may indicate chromosomal abnormalities, where some cells exhibit a normal chromosome count while others show signs of breakage or translocation.

3. Post-Procedure

After the chromosome analysis is completed, the results are compiled and interpreted by a qualified geneticist or pathologist. The findings can provide critical information for diagnosing breakage syndromes and guiding further clinical management. Patients may require additional follow-up testing or genetic counseling based on the results. It is essential to communicate the findings clearly to the healthcare team and the patient to ensure appropriate care and support. Additionally, any identified chromosomal abnormalities may necessitate monitoring for associated health risks, including cancer predisposition, depending on the specific breakage syndrome diagnosed.